The SURFeye project of advanced ocular surface therapy, in which BTI has participated, concludes
The 'SURFeye' project has completed its path, after three years of research in the area of ocular surface pathologies, developing advanced therapies and diagnostic systems for diseases of the ocular surface.
In order to carry out the project, a consortium composed of a group of companies was set up, with outstanding participation of BTI Biotechnology Institute, the Fernández-Vega Ophthalmological Research Foundation and the public centers University of Santiago de Compostela and University of the Basque Country.
|The news in the media:|
|Infosalus||El Economista||La Información|
|Diario Siglo XXI||Saludigestivo||Bolsamanía|
|Sabor 809||Diario Multimedia||La Voz Libre|